Bryan, Garnier & Co Reiterates Buy Rating for Shire PLC (SHP)
Shire PLC (LON:SHP)‘s stock had its “buy” rating reaffirmed by investment analysts at Bryan, Garnier & Co in a research report issued to clients and investors on Monday. They presently have a GBX 6,900 ($84.10) price objective on the biopharmaceutical company’s stock. Bryan, Garnier & Co’s price target points to a potential upside of 34.08% from the stock’s current price.
Several other equities research analysts also recently issued reports on SHP. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 6,300 ($76.78) target price (up previously from GBX 5,600 ($68.25)) on shares of Shire PLC in a research report on Monday, August 1st. Jefferies Group increased their target price on Shire PLC from GBX 6,050 ($73.74) to GBX 6,600 ($80.44) and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. Deutsche Bank AG restated a “buy” rating and set a GBX 6,000 ($73.13) target price on shares of Shire PLC in a research report on Monday, September 19th. Citigroup Inc. restated a “buy” rating on shares of Shire PLC in a research report on Wednesday, July 13th. Finally, Credit Suisse Group AG increased their target price on Shire PLC from GBX 5,000 ($60.94) to GBX 5,200 ($63.38) and gave the stock an “outperform” rating in a research report on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of GBX 5,907.50 ($72.00).
Shares of Shire PLC (LON:SHP) opened at 5144.00 on Monday. The company’s 50-day moving average price is GBX 5,022.47 and its 200-day moving average price is GBX 4,625.73. The company’s market cap is GBX 35.12 billion. Shire PLC has a 12 month low of GBX 2,707.19 and a 12 month high of GBX 5,377.00.
The company also recently announced a dividend, which was paid on Friday, October 7th. Investors of record on Thursday, September 8th were paid a GBX 3.51 ($0.04) dividend. The ex-dividend date of this dividend was Thursday, September 8th. This represents a yield of 0.07%.
In related news, insider Dominic Blakemore acquired 133 shares of Shire PLC stock in a transaction dated Friday, September 30th. The shares were purchased at an average cost of GBX 5,010 ($61.06) per share, with a total value of £6,663.30 ($8,121.02).
About Shire PLC
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.